tiprankstipranks
Trending News
More News >
STRATEC Biomedical AG (GB:0RAR)
LSE:0RAR
UK Market

STRATEC Biomedical (0RAR) Income Statement

Compare
1 Followers

STRATEC Biomedical Income Statement

Last quarter (Q3 2025), STRATEC Biomedical's total revenue was €57.00M, a decrease of -0.40% from the same quarter last year. In Q3, STRATEC Biomedical's net income was €1.50M. See STRATEC Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 257.62M€ 270.41M€ 274.63M€ 287.33M€ 250.10M
Gross Profit
€ 76.39M€ 68.16M€ 79.49M€ 87.71M€ 68.99M
Operating Expenses
€ 48.20M€ 40.04M€ 37.49M€ 38.08M€ 36.54M
Depreciation and Amortization
€ 19.43M€ 17.69M€ 16.93M€ 18.25M€ 22.59M
EBITDA
€ 47.34M€ 43.16M€ 57.53M€ 66.52M€ 56.72M
Operating Income
€ 28.18M€ 28.12M€ 42.00M€ 49.63M€ 32.48M
Other Income/Expenses
€ -6.17M€ -6.58M€ -2.91M€ -2.80M€ 576.00K
Pretax Income
€ 22.01M€ 21.55M€ 39.09M€ 46.83M€ 33.02M
Net Income
€ 16.02M€ 15.37M€ 29.22M€ 39.96M€ 25.18M
Per Share Metrics
Basic EPS
€ 1.32€ 1.26€ 2.41€ 3.30€ 2.42
Diluted EPS
€ 1.32€ 1.26€ 2.40€ 3.28€ 2.40
Weighted Average Shares Outstanding
12.16M 12.16M 12.13M 12.11M 12.06M
Weighted Average Shares Outstanding (Diluted)
12.16M 12.16M 12.17M 12.18M 12.15M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History